Triptonide is a reversible non-hormonal male contraceptive agent in mice and non-human primates
2021 · Nature Communications · 110 citations
https://doi.org/10.1038/s41467-021-21517-5
Y
Yu Zhou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
1.1K
Citations
17
h-index
24
i10-index
Yu Zhou is an academic researcher from Guiyang Medical University. The author has contributed to research in topics: MicroRNA in disease regulation & Pregnancy and preeclampsia studies & Cancer-related molecular mechanisms research. The author has an h-index of 17, co-authored 55 publications.
ORCID: 0000-0003-0457-221XPapers by this author
worksRNA 5-methylcytosine regulates YBX2-dependent liquid-liquid phase separation
2021 · Fundamental Research · 35 citations
https://doi.org/10.1016/j.fmre.2021.10.008
Intronic polymorphisms in genes LRFN2 (rs2494938) and DNAH11 (rs2285947) are prognostic indicators of esophageal squamous cell carcinoma
2019 · BMC Medical Genetics · 11 citations
https://doi.org/10.1186/s12881-019-0796-9
<scp>LRFN2</scp> binding to <scp>NMDAR</scp> inhibits the progress of <scp>ESCC</scp> via regulating the Wnt/<scp>β‐Catenin</scp> and <scp>NF‐κB</scp> signaling pathway
2022 · Cancer Science · 10 citations
https://doi.org/10.1111/cas.15510
Binding of mAbs to cancer cell lines that overexpress the target antigens as determined by fluorescent microscopy.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0111339.g008
Effects of anti-ganglioside GD2 14G2a monoclonal antibody (mAb) alone or in combination with ET A receptor (ETAR) antagonist on osteosarcoma (OS) cell invasiveness.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0093576.g002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat